Related Experiment Video
Updated: Jul 18, 2026
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
[Epidermoid carcinoma larynx in stage IV]
J Herranz González-Botas1, J C Vázquez Barro
1Servicio de Otorrinolaringología, Hospital Universitario Juan Canalejo, A Coruña. jhg@canalejo.org
Objective:
To determine the survival, loco-regional control, distant metastases and second primary in stage IV laryngeal carcinoma treated by surgery and radiotherapy.
Material:
Retrospective study of 147 patients treated with surgery and radiotherapy with a 5 year minimun follow-up.
Results:
Overall and cause specific survival at 5 and 10 years was 42%, 35% and 49%, 45.8% respectively. Loco-regional control was 57.7 % and 54.7% at 5 and 10 years. Local recurrences presented in 25.7%, regional recurrences in 74.2%, and distant metastases 10.9%. Second primary tumors developed in 12% of the patients, 50% of the cases in the lungs. Factors related to survival are evaluated.
Conclusions:
In our experience, surgery with postoperative radiotherapy in N+, controls 45% of stage IV laryngeal carcinoma. Regional recurrencies are the main cause of failure, more frequent in N+ patientes, present in the first 36 months after treatment.
